JPRN-UMIN000006050已完成未知
Follow-up survey following the completion of 'A open-label, randomized controlled study of adjuvant therapy with TAP-144-SR (3M) in premenopausal breast cancer patients' - Follow-up survey following TAP-144-SR (3M) study
Public Health Research Foundation. Comprehensive Support Project for Oncology Research0 个研究点目标入组 222 人开始时间: 2011年10月1日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 222
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1) The subject has received preoperative hormone therapy prior to breast cancer surgery. 2) The subject has received postoperative adjuvant hormone therapy prior to the study enrollment. 3) The subject has received bilateral oophorectomy and irradiation to bilateral ovaries. 4) The subject has inflammatory breast cancer or bilateral breast cancer. 5) The subject has double cancer or has a history of carcinoma in other organs. 6) The subject is pregnant or breast-feeding, and of child-bearing potential. 7) The subject has past history of hypersensitivity to the study drug component or synthetic LH-RH, LH-RH derivative, and TAM or TAM analogue (antiestrogen). 8) The subject has severe complications.
研究者
相似试验
招募中
不适用
Follow-up study of subjects who participated in the IUGR-1, IUGR-2 and PROGRAM/PREMS study during childhood and early adulthood - Long term effects of growth hormone many years after discontinuatiocardiovasculaire ziektesShort children born small for gestational age1001842410013356NL-OMON47841Erasmus MC, Universitair Medisch Centrum Rotterdam400
已完成
Unknown
An observational study after completion of a multicenter open-label uncontrolled trial in pleurodesis for secondary intractable pneumothorax with sterile graded talcPatients who participated in an investigator-initiated phase II study in pleurodesis for secondary intractable pneumothorax with sterile graded talc (protocol number: J-TALC2) with absence of chest tube removal within 30 days after pleurodesis, and who still have been hospitalized.JPRN-jRCT1091220271ational Hospital Organization Nagoya Medical Center Hideo Saka30
已完成
不适用
The follow up study of "Phase l / ll Study of S-1+oxaliplatin (SOX)+cetuximab as first Line therapy in metastatic colorectal cancer with EGFR-detectable and KRAS wild type (JACCRO CC-06)".metastatic colorectal cancerJPRN-UMIN000027014Japan Clinical Cancer Research Organization33
已完成
2 期
A follow-up study to investigate the functionality of a glucose sensor device in the human eye.Diabetes type 1Insulin-dependent diabetes mellitus10012653NL-OMON46205oviosense BV24
已完成
不适用
Follow-up survey 1 year after a current status investigation of external treatment for plaque psoriasispsoriasis vulgarisJPRN-UMIN000023946Topical-therapy Survey Study Group for Psoriasis250